Literature DB >> 20381798

Endoscopic submucosal dissection for treatment of rectal carcinoid tumors.

Hye-Won Park1, Jeong-Sik Byeon, Young Soo Park, Dong-Hoon Yang, Soon Man Yoon, Kyung-Jo Kim, Byong Duk Ye, Seung-Jae Myung, Suk-Kyun Yang, Jin-Ho Kim.   

Abstract

BACKGROUND: Conventional EMR has been the endoscopic treatment of choice for rectal carcinoid tumors. However, histologically complete resection often cannot be achieved because the carcinoid tumors are located mainly in the submucosal layer. Endoscopic submucosal dissection (ESD), a new method for large colorectal neoplasm resection, may overcome this problem.
OBJECTIVE: To compare ESD with EMR for the endoscopic treatment of rectal carcinoid tumors.
DESIGN: A prospective case series with comparison to retrospective controls.
SETTING: Tertiary-care center. PATIENTS: From January 2007 to January 2009 we prospectively enrolled consecutive patients with rectal carcinoid tumors less than 16 mm in diameter and with no regional lymph node enlargement shown by CT or EUS. For comparison, we retrospectively randomly selected patients who had undergone EMR for treatment of rectal carcinoid tumors between March 2000 and December 2006. INTERVENTION: We performed ESD of rectal carcinoid tumors in prospectively enrolled patients. MAIN OUTCOME MEASUREMENTS: Rate of en bloc resection, rate of histologically complete resection, incidence of complications, and length of procedures.
RESULTS: The ESD group contained 31 patients (18 male, 13 female; age range 34-65 years), and the EMR group contained 62 patients (42 male, 20 female; age range 22-77 years). Both groups had similar mean rectal carcinoid tumor diameters (ESD 6.8 +/- 2.4 mm, EMR 7.3 +/- 2.2 mm; P = .106). Resection time was longer in the ESD group than in the EMR group (11.4 +/- 3.7 minutes vs 4.2 +/- 3.2 minutes, P < .001). The en bloc resection rate was 100% (31 of 31) in the ESD group and 95.2% (59 of 62) in the EMR group (P = .213). The histologically complete resection rate was 90.3% (28 of 31) in the ESD group and 71.0% (44 of 62) in the EMR group (P = .035). Suspected perforation occurred in 1 ESD patient (3.2%) and in 1 EMR patient (1.6%), and both patients were successfully managed by conservative measures. Immediate bleeding occurred in 1 ESD patient (3.2%) and in 4 EMR patients (6.5%); all instances of bleeding were controlled endoscopically. LIMITATIONS: Retrospective control study and limited experience at a single center.
CONCLUSION: Compared with EMR, ESD resulted in a higher histologically complete resection rate, had a similar complication rate, and took slightly longer to perform. Given the advantages of complete resection, these findings indicate that ESD may be considered for treatment of rectal carcinoid tumors. Copyright 2010 American Society for Gastrointestinal Endoscopy. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20381798     DOI: 10.1016/j.gie.2010.01.040

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  50 in total

1.  Endoscopic submucosal dissection for colorectal tumors--1,000 colorectal ESD cases: one specialized institute's experiences.

Authors:  Eun-Jung Lee; Jae Bum Lee; Suk Hee Lee; Do Sun Kim; Doo Han Lee; Doo Seok Lee; Eui Gon Youk
Journal:  Surg Endosc       Date:  2012-06-23       Impact factor: 4.584

Review 2.  Which endoscopic treatment is the best for small rectal carcinoid tumors?

Authors:  Hyun Ho Choi; Jin Su Kim; Dae Young Cheung; Young-Seok Cho
Journal:  World J Gastrointest Endosc       Date:  2013-10-16

3.  A tailored approach for endoscopic treatment of small rectal neuroendocrine tumor.

Authors:  Jun Heo; Seong Woo Jeon; Min Kyu Jung; Sung Kook Kim; Geun Young Shin; Sang Man Park; Sun Young Ahn; Won Kyung Yoon; Min Kim; Yong Hwan Kwon
Journal:  Surg Endosc       Date:  2014-05-23       Impact factor: 4.584

4.  Efficacy of endoscopic mucosal resection using a dual-channel endoscope compared with endoscopic submucosal dissection in the treatment of rectal neuroendocrine tumors.

Authors:  Wook-Hyun Lee; Sang-Woo Kim; Chul-Hyun Lim; Jin-Soo Kim; Yu-Kyung Cho; In-Seok Lee; Myung-Gyu Choi; Kyu-Yong Choi
Journal:  Surg Endosc       Date:  2013-06-27       Impact factor: 4.584

5.  A comparison of endoscopic treatments in rectal carcinoid tumors.

Authors:  Hyun Joo Lee; Seong Beom Kim; Cheol Min Shin; A Young Seo; Dong Ho Lee; Nayoung Kim; Young Soo Park; Hyuk Yoon
Journal:  Surg Endosc       Date:  2015-10-30       Impact factor: 4.584

6.  Endoscopic submucosal dissection (ESD) versus transanal endoscopic microsurgery (TEM) for treatment of rectal tumors: a comparative systematic review and meta-analysis.

Authors:  Thomas R McCarty; Ahmad Najdat Bazarbashi; Kelly E Hathorn; Christopher C Thompson; Hiroyuki Aihara
Journal:  Surg Endosc       Date:  2019-07-10       Impact factor: 4.584

7.  Endoscopic resection for rectal carcinoid tumors: comparison of polypectomy and endoscopic submucosal resection with band ligation.

Authors:  Sang Heon Lee; Seun Ja Park; Hyung Hun Kim; Kyung Sun Ok; Ji Hyun Kim; Sam Ryong Jee; Sang Young Seol; Bo Mi Kim
Journal:  Clin Endosc       Date:  2012-03-31

8.  Factors associated with complete local excision of small rectal carcinoid tumor.

Authors:  Hae-Jung Son; Dae Kyung Sohn; Chang Won Hong; Kyung Su Han; Byung Chang Kim; Ji Won Park; Hyo Seong Choi; Hee Jin Chang; Jae Hwan Oh
Journal:  Int J Colorectal Dis       Date:  2012-07-22       Impact factor: 2.571

Review 9.  Rectal carcinoids: a systematic review.

Authors:  Frank D McDermott; Anna Heeney; Danielle Courtney; Helen Mohan; Des Winter
Journal:  Surg Endosc       Date:  2014-03-01       Impact factor: 4.584

10.  Endoscopic submucosal dissection for foregut neuroendocrine tumors: an initial study.

Authors:  Quan-Lin Li; Yi-Qun Zhang; Wei-Feng Chen; Mei-Dong Xu; Yun-Shi Zhong; Li-Li Ma; Wen-Zheng Qin; Jian-Wei Hu; Ming-Yan Cai; Li-Qing Yao; Ping-Hong Zhou
Journal:  World J Gastroenterol       Date:  2012-10-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.